CBB-120

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameCBB-120
Drug Alias NameCBB-120CBB120CB-120CB120
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Trop-2DNA topoisomerase I inhibitorsSerine-protein kinase ATR inhibitors
TargetsTumor-associated calcium signal transducer 2DNA topoisomerase ISerine-protein kinase ATR
Therapy Area/IndicationsSolid tumoursTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossBridge Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossBridge Bio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A